NCT00218218View on ClinicalTrials.gov

Effects of Transdermal Nicotine on Smoking, Craving and Withdrawal in People With Schizophrenia

PHASE2CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

June 30, 2002

Primary Completion Date

February 28, 2005

Study Completion Date

February 28, 2005

Conditions
Schizophrenia and Disorders With Psychotic FeaturesTobacco Use DisorderSchizophrenia
Interventions
DRUG

Transdermal Nicotine Patch

42 mg transdermal nicotine

DRUG

21 mg transdermal nicotine

DRUG

placebo patch

Trial Locations (2)

02908

Providence VA Medical Center, Providence

02912

Brown University, Providence

All Listed Sponsors
lead

National Institute on Drug Abuse (NIDA)

NIH

NCT00218218 - Effects of Transdermal Nicotine on Smoking, Craving and Withdrawal in People With Schizophrenia | Biotech Hunter | Biotech Hunter